Also trades as: HSCSW (NASDAQ) · $vol 0M
HSCS NASDAQ
HeartSciences Inc.
1W: -9.1%
1M: +42.9%
3M: +59.3%
YTD: +36.9%
1Y: +20.4%
3Y: -89.8%
$4.30
+0.41 (+10.54%)
Weekly Expected Move ±21.4%
$2
$3
$4
$5
$6
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$4K
-0.7% ▼
5Y CAGR: -29.9%
Gross Profit
-$129K
-2.6% ▼
Operating Income
-$8M
-0.7% ▼
Net Income
-$9M
-4.3% ▼
EPS (Diluted)
$-3.48
+62.7% ▲
EBITDA
-$8M
-2.3% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $14K | $5K | $19K | $4K | $4K |
| YoY Growth | -43.9% | -64.2% | +261.2% | -76.6% | -0.7% |
| Cost of Revenue | $34K | $30K | $101K | $130K | $133K |
| Gross Profit | -$20K | -$25K | -$83K | -$125K | -$129K |
| Gross Margin | -139.7% | -476.9% | -444.2% | -2884.7% | -2982.1% |
| R&D Expenses | $3M | $2M | $3M | $4M | $2.8B |
| SG&A Expenses | $2M | $4M | $3M | $4M | $5.6B |
| Operating Expenses | $5M | $6M | $6M | $8M | $8M |
| Operating Income | -$5M | -$6M | -$6M | -$8M | -$8M |
| Operating Margin | -32765.6% | -118698.3% | -33902.0% | -192013.1% | -194787.4% |
| Interest Expense | $372K | $243K | $354K | $500K | $753K |
| Income Before Tax | -$5M | -$6M | -$7M | -$9M | -$9M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$5M | -$6M | -$7M | -$9M | -$9M |
| Net Margin | -33592.6% | -123384.3% | -35511.9% | -201499.5% | -211666.5% |
| EPS (Diluted) | $-137.94 | $-6173.88 | $-18.74 | $-9.34 | $-3.48 |
| EBITDA | -$4M | -$6M | -$6M | -$8M | -$8M |
| Shares Outstanding | 33189 | 79505 | 352520 | 938257 | 3M |